Dr Lal Path Labs declares 1:1 bonus issue and Rs 7 interim dividend amid diagnostic demand surge

Dr Lal Path Labs announced a 1:1 bonus share issue and declared an interim dividend of Rs 7 per share for FY 2025–26, underscoring strong confidence in its earnings trajectory and operational efficiency. The diagnostic major continues to benefit from robust testing demand, digital booking channels, and increased preventive healthcare awareness. Market observers said the payout aligns with healthy cash reserves and sustained revenue growth. The move highlights continued optimism in India’s expanding healthcare diagnostics market driven by urbanization and higher insurance penetration.